发明名称 |
PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR |
摘要 |
Light-generating fusion proteins having a ligand binding site and a light-generating polypeptide moiety and their use as diagnostics, in drug screening and discovery, and as therapeutics, are disclosed. The light-generating fusion protein has a feature where the bioluminescence of the polypeptide moiety changes upon binding of a ligand at the ligand binding site. The ligand may be, for example, an enzyme present in an environment only under certain conditions, e.g., ubiquitin ligase in a hypoxic state, such that the light-generating fusion protein is “turned on” only under such conditions. |
申请公布号 |
US2015010576(A1) |
申请公布日期 |
2015.01.08 |
申请号 |
US201414328588 |
申请日期 |
2014.07.10 |
申请人 |
Dana Farber Cancer Institute, Inc. |
发明人 |
Kaelin, JR. William G.;Ivan Mircea |
分类号 |
G01N33/573 |
主分类号 |
G01N33/573 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of identifying prolyl hydroxylase modulators, comprising the steps of: a) contacting a prolyl hydroxylase, a putative prolyl hydroxylase modulator and a light-generating fusion protein comprising an HIFα polypeptide moiety having binding character for prolyl hydroxylase and a light-generating polypeptide moiety, wherein the light generation of said light-generating polypeptide moiety changes upon binding of a prolyl hydroxylase to said HIFα polypeptide moiety, under conditions favorable for binding of a prolyl hydroxylase to a HIFα to form a test sample; and b) determining the ability of said putative prolyl hydroxylase modulator to modulate prolyl hydroxylase by measuring the light generated in said test sample. |
地址 |
Boston MA US |